Guardion Health Sciences Announces Financial Results for the Three Months Ended June 30, 2021, including $1,000,000+ of Sales from Viactiv® Products in the First Month of Guardion’s Ownership
August 16, 2021 08:15 ET
|
Guardion Health Sciences, Inc.
HOUSTON, Aug. 16, 2021 (GLOBE NEWSWIRE) -- Guardion Health Sciences, Inc. (Nasdaq: GHSI) (“Guardion” or the “Company”), a clinical nutrition and diagnostics company that develops clinically...
Guardion Health Sciences to Exhibit at the American Society of Cataract and Refractive Surgery Annual Meeting
July 22, 2021 16:15 ET
|
Guardion Health Sciences, Inc.
SAN DIEGO, July 22, 2021 (GLOBE NEWSWIRE) -- Guardion Health Sciences, Inc. (Nasdaq: GHSI) (“Guardion” or the “Company”), a clinical nutrition and diagnostics company that develops clinically...
Guardion Health Sciences to Be Added to the Russell 3000 Index
June 14, 2021 08:05 ET
|
Guardion Health Sciences, Inc.
SAN DIEGO, June 14, 2021 (GLOBE NEWSWIRE) -- Guardion Health Sciences, Inc. (Nasdaq: GHSI) (“Guardion” or the “Company”), a clinical nutrition and diagnostics company that develops clinically...
Guardion Health Sciences Announces Appointment of Craig J. Sheehan as Chief Commercial Officer
June 03, 2021 08:17 ET
|
Guardion Health Sciences, Inc.
SAN DIEGO, June 03, 2021 (GLOBE NEWSWIRE) -- Guardion Health Sciences, Inc. (Nasdaq: GHSI) (“Guardion” or the “Company”), a clinical nutrition and diagnostics company that develops clinically...
Guardion Health Sciences Broadens Clinical Nutrition Product Offerings by Closing Acquisition of Activ Nutritional, which owns the Science Backed, Revenue-Generating Viactiv® Product Line, from Adare Pharmaceuticals
June 02, 2021 09:07 ET
|
Guardion Health Sciences, Inc.
Acquisition to Transform and Strengthen Guardion’s Clinical Nutrition Product Portfolio Guardion Will Continue to Explore Additional Growth Opportunities to Further Expand its Presence in the...
Guardion Health Sciences to Present at the LD Micro Virtual Invitational Conference on June 9, 2021
June 02, 2021 08:03 ET
|
Guardion Health Sciences, Inc.
SAN DIEGO, June 02, 2021 (GLOBE NEWSWIRE) -- Guardion Health Sciences, Inc. (Nasdaq: GHSI), a clinical nutrition and diagnostics company that develops clinically supported nutrition, supplements,...
Guardion Health Sciences to Acquire Activ Nutritional, LLC and Its Well-Known Viactiv® Brand of Products from Adare Pharmaceuticals, Inc.
May 18, 2021 09:25 ET
|
Guardion Health Sciences, Inc.
Acquisition to Transform and Strengthen Guardion’s Clinical Nutrition Product Portfolio Guardion Will Continue to Explore Additional Growth Opportunities to Further Expand its Presence in the...
Guardion Health Sciences Announces Financial Results for the Three Months Ended March 31, 2021
May 17, 2021 16:05 ET
|
Guardion Health Sciences, Inc.
SAN DIEGO, May 17, 2021 (GLOBE NEWSWIRE) -- Guardion Health Sciences, Inc. (Nasdaq: GHSI) (“Guardion” or the “Company”), a clinical nutrition and diagnostics company that develops clinically...
Guardion Health Sciences Initiates Placebo-Controlled Clinical Trial Involving Proprietary GlaucoCetin® Product
May 03, 2021 08:10 ET
|
Guardion Health Sciences, Inc.
SAN DIEGO, May 03, 2021 (GLOBE NEWSWIRE) -- Guardion Health Sciences, Inc. (Nasdaq: GHSI) (“Guardion” or the “Company”), a clinical nutrition and diagnostics company that develops clinically...
Guardion Health Sciences Announces Financial Results for the Three Months and Year Ended December 31, 2020
March 26, 2021 08:00 ET
|
Guardion Health Sciences, Inc.
SAN DIEGO, March 26, 2021 (GLOBE NEWSWIRE) -- Guardion Health Sciences, Inc. (Nasdaq: GHSI) (“Guardion” or the “Company”), a clinical nutrition and diagnostics company that develops science-based,...